Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
SilverSun Technologies to Present at The MicroCap Conference on April 9th and 10th in New York City at the Essex House
-
UPDATE: Maxim Group Upgrades SELLAS Life Sciences Group (SLS) to Buy
-
PeerStream, Inc. to Present at The MicroCap Conference on April 9th and 10th in New York City at the Essex House
-
Del Taco Restaurants (TACO) PT Lowered to $19 at Maxim Group
-
Pre-Open Movers 03/15: (SMRT) (RUBI) (CWAY) Higher; (SLDB) (JILL) (SPEX) Lower (more...)
-
UPDATE: Maxim Group Upgrades Galmed Pharmaceuticals (GLMD) to Buy; Favorable Risk/Reward
-
Sino-Global Announces Closing of $3 Million Registered Direct Offering
-
AnalytixInsight Inc. to Present at The MicroCap Conference on April 9th and 10th in New York City at the Essex House
-
Ecoark Announces $4.2 Million Registered Direct Offering
-
Nutanix (NTNX) PT Raised to $71 at Maxim Citing Improved LT Sales Productivity Forecast
-
Virtusa (VRTU) PT Raised to $64 at Maxim Group
-
Maxim Group Downgrades Can-Fite BioPharma (CANF) to Hold Citing Dilutive Capital Raise
-
Sino-Global Shipping America (SINO) Prices $3 Million Registered Direct Offering
-
Sino-Global Announces Pricing of $3 Million Registered Direct Offering
-
Royalty Flow IPO Requalified By SEC
-
National Beverage (FIZZ) PT Raised to $45 at Maxim Group
-
Coherus Biosciences (CHRS) PT Lowered to $15 at Maxim Group
-
Cytori Therapeutics, Inc. (CYTX) PT Lowered to $2 at Maxim Group
-
CytoSorbents Achieves Record Revenue and Product Sales Growth in 2017
-
Maxim Group Downgrades Express Scripts (ESRX) to Hold Following Acquisition
-
Maxim Group Downgrades THL Credit (TCRD) to Hold
-
Grande West Transportation Group Inc. to Present at The MicroCap Conference on April 9th and 10th in New York City at the Essex House
-
Oragenics, Inc. to Present at The MicroCap Conference on April 9th and 10th in New York City at the Essex House
-
Encision Inc. to Present at The MicroCap Conference on April 9th and 10th in New York City at the Essex House
-
BioLineRx (BLRX) PT Lowered to $2 at Maxim Group
-
VMware (VMW) PT Raised to $134 at Maxim Group
-
Maxim Group Downgrades Sonoma Pharmaceuticals (SNOA) to Hold
-
Beyond Commerce, Inc. Retains Maxim Group, LLC
-
Whitestone REIT (WSR) PT Lowered to $16 at Maxim Group
-
Actinium Announces $15.4 Million in Expected Gross Proceeds from Recently Expired Rights Offering
-
Actinium Announces $15.4 Million in Expected Gross Proceeds from Recently Expired Rights Offering
-
Vertex (VRTX) PT Raised to $200 at Maxim Group
-
RegeneRx Secures $1 Million in Funding
-
Nutanix (NTNX) PT Raised to $54 at Maxim Group
-
Pure Storage (PSTG) PT Raised to $21 at Maxim Group
-
Splunk (SPLK) PT Raised to $116 at Maxim Group
-
Habit Restaurants (HABT) PT Lowered to $12 at Maxim Group
-
BeiGene, Ltd. (BGNE) PT Raised to $160 at Maxim Group
-
Express Scripts (ESRX) PT Raised to $101 at Maxim Group Citing Tax Reform/Better-Than-Expects Results
-
Maxim Group Downgrades MannKind (MNKD) to Sell; Sees Potential Bankruptcy
-
Stellar Acquisition III (STLR) to Combine with Phunware, Inc. and Enter Mobile Cloud Software and Blockchain Sectors
-
Stellar Acquisition III, Inc. Signs Definitive Agreement to Combine with Phunware, Inc. and Enter the Mobile Cloud Software and Blockchain Sectors
-
Alarm.com (ALRM) PT Raised to $59 at Maxim Group
-
Helios and Matheson Analytics (HMNY) PT Lowered to $16 at Maxim Group
-
Maxim Group Starts Payment Data Systems, Inc. (PYDS) at Buy
-
Palo Alto Networks (PANW) PT Raised to $212 at Maxim Group
-
Actinium Pharmaceuticals Reiterates Previously Announced Expiration Date of March 2, 2018 at 5:00 PM ET and Amendment to Pricing Terms of its Rights Offering
-
Actinium Pharmaceuticals Reiterates Previously Announced Expiration Date of March 2, 2018 at 5:00 PM ET and Amendment to Pricing Terms of its Rights Offering
-
ManTech (MANT) PT Raised to $59 at Maxim Group; ' On Industry Leading Growth and Stronger Free Cash Flow'
-
DineEquity (DIN) PT Raised to $87 at Maxim Group; 'Improved Visibility Warrants Multiple Expansion'

